Brombensener
Filtrerade sökresultat
4-Bromoaniline, 99+%
CAS: 106-40-1 Molekylformel: C6H6BrN Molekylvikt (g/mol): 172.02 InChI-nyckel: WDFQBORIUYODSI-UHFFFAOYSA-N Synonym: p-bromoaniline,4-bromobenzenamine,benzenamine, 4-bromo,p-bromophenylamine,aniline, p-bromo,4-bromo-aniline,4-bromobenzeneamine,p-bromo aniline,4-bromanilinu,4-bromo-phenylamine PubChem CID: 7807 IUPAC-namn: 4-bromanilin LEDER: C1=CC(=CC=C1N)Br
| Molekylformel | C6H6BrN |
|---|---|
| PubChem CID | 7807 |
| IUPAC-namn | 4-bromanilin |
| CAS | 106-40-1 |
| InChI-nyckel | WDFQBORIUYODSI-UHFFFAOYSA-N |
| LEDER | C1=CC(=CC=C1N)Br |
| Molekylvikt (g/mol) | 172.02 |
| Synonym | p-bromoaniline,4-bromobenzenamine,benzenamine, 4-bromo,p-bromophenylamine,aniline, p-bromo,4-bromo-aniline,4-bromobenzeneamine,p-bromo aniline,4-bromanilinu,4-bromo-phenylamine |
4-bromanilin, 96 %, praxis, Thermo Scientific Chemicals
CAS: 106-40-1 Molekylformel: C6H6BrN Molekylvikt (g/mol): 172.02 MDL-nummer: MFCD00007822 InChI-nyckel: WDFQBORIUYODSI-UHFFFAOYSA-N Synonym: p-bromoaniline,4-bromobenzenamine,benzenamine, 4-bromo,p-bromophenylamine,aniline, p-bromo,4-bromo-aniline,4-bromobenzeneamine,p-bromo aniline,4-bromanilinu,4-bromo-phenylamine PubChem CID: 7807 IUPAC-namn: 4-bromanilin LEDER: C1=CC(=CC=C1N)Br
| Molekylformel | C6H6BrN |
|---|---|
| PubChem CID | 7807 |
| MDL-nummer | MFCD00007822 |
| IUPAC-namn | 4-bromanilin |
| CAS | 106-40-1 |
| InChI-nyckel | WDFQBORIUYODSI-UHFFFAOYSA-N |
| LEDER | C1=CC(=CC=C1N)Br |
| Molekylvikt (g/mol) | 172.02 |
| Synonym | p-bromoaniline,4-bromobenzenamine,benzenamine, 4-bromo,p-bromophenylamine,aniline, p-bromo,4-bromo-aniline,4-bromobenzeneamine,p-bromo aniline,4-bromanilinu,4-bromo-phenylamine |
1-Bromo-3,4-dichlorobenzene, 98+%
CAS: 18282-59-2 Molekylformel: C6H3BrCl2 Molekylvikt (g/mol): 225.89 MDL-nummer: MFCD00040849 InChI-nyckel: CFPZDVAZISWERM-UHFFFAOYSA-N Synonym: 1-bromo-3,4-dichlorobenzene,3,4-dichlorobromobenzene,benzene, 4-bromo-1,2-dichloro,3,4-dichlorophenyl bromide,3,4-dichloro-1-bromobenzene,4-bromo-1,2-dichloro-benzene,5-bromdichlorbenzol,pubchem3611,acmc-1btol,3,4-dichloro-bromobenzene PubChem CID: 29013 IUPAC-namn: 4-brom-1,2-diklorbensen LEDER: ClC1=CC=C(Br)C=C1Cl
| Molekylformel | C6H3BrCl2 |
|---|---|
| PubChem CID | 29013 |
| MDL-nummer | MFCD00040849 |
| IUPAC-namn | 4-brom-1,2-diklorbensen |
| CAS | 18282-59-2 |
| InChI-nyckel | CFPZDVAZISWERM-UHFFFAOYSA-N |
| LEDER | ClC1=CC=C(Br)C=C1Cl |
| Molekylvikt (g/mol) | 225.89 |
| Synonym | 1-bromo-3,4-dichlorobenzene,3,4-dichlorobromobenzene,benzene, 4-bromo-1,2-dichloro,3,4-dichlorophenyl bromide,3,4-dichloro-1-bromobenzene,4-bromo-1,2-dichloro-benzene,5-bromdichlorbenzol,pubchem3611,acmc-1btol,3,4-dichloro-bromobenzene |
3-bromanilin, 98 %, Thermo Scientific Chemicals
CAS: 591-19-5 Molekylformel: C6H6BrN Molekylvikt (g/mol): 172.03 MDL-nummer: MFCD00007757 InChI-nyckel: DHYHYLGCQVVLOQ-UHFFFAOYSA-N Synonym: m-bromoaniline,benzenamine, 3-bromo,3-bromo aniline,m-aminobromobenzene,aniline, m-bromo,3-bromobenzenamine,3-bromophenylamine,bromoaniline 3-,3-bromo-benzenamine,3-bromo-phenylamine PubChem CID: 11562 IUPAC-namn: 3-bromanilin LEDER: NC1=CC=CC(Br)=C1
| Molekylformel | C6H6BrN |
|---|---|
| PubChem CID | 11562 |
| MDL-nummer | MFCD00007757 |
| IUPAC-namn | 3-bromanilin |
| CAS | 591-19-5 |
| InChI-nyckel | DHYHYLGCQVVLOQ-UHFFFAOYSA-N |
| LEDER | NC1=CC=CC(Br)=C1 |
| Molekylvikt (g/mol) | 172.03 |
| Synonym | m-bromoaniline,benzenamine, 3-bromo,3-bromo aniline,m-aminobromobenzene,aniline, m-bromo,3-bromobenzenamine,3-bromophenylamine,bromoaniline 3-,3-bromo-benzenamine,3-bromo-phenylamine |
4-Bromo-2-fluorobenzonitrile, 99+%
CAS: 105942-08-3 Molekylformel: C7H3BrFN Molekylvikt (g/mol): 200.01 MDL-nummer: MFCD00143264 InChI-nyckel: HGXWRDPQFZKOLZ-UHFFFAOYSA-N Synonym: 2-fluoro-4-bromobenzonitrile,4-bromo-2-fluoro-benzonitrile,benzonitrile, 4-bromo-2-fluoro,4-bromo-2-fluorobenzenecarbonitrile,4-cyano-3-fluorobromobenzene,pubchem3221,2-floro-4-bromobenzonitrile,4-bromo-2-fluorobenzontrile,4-bromo-6-fluorobenzonitrile,ksc490q4t PubChem CID: 736029 IUPAC-namn: 4-brom-2-fluorbensonitril LEDER: FC1=CC(Br)=CC=C1C#N
| Molekylformel | C7H3BrFN |
|---|---|
| PubChem CID | 736029 |
| MDL-nummer | MFCD00143264 |
| IUPAC-namn | 4-brom-2-fluorbensonitril |
| CAS | 105942-08-3 |
| InChI-nyckel | HGXWRDPQFZKOLZ-UHFFFAOYSA-N |
| LEDER | FC1=CC(Br)=CC=C1C#N |
| Molekylvikt (g/mol) | 200.01 |
| Synonym | 2-fluoro-4-bromobenzonitrile,4-bromo-2-fluoro-benzonitrile,benzonitrile, 4-bromo-2-fluoro,4-bromo-2-fluorobenzenecarbonitrile,4-cyano-3-fluorobromobenzene,pubchem3221,2-floro-4-bromobenzonitrile,4-bromo-2-fluorobenzontrile,4-bromo-6-fluorobenzonitrile,ksc490q4t |
1-brom-2,4-dimetoxibensen, 98 %, Thermo Scientific™
CAS: 17715-69-4 Molekylformel: C8H9BrO2 Molekylvikt (g/mol): 217.06 MDL-nummer: MFCD00009844 InChI-nyckel: NIUZVSQOXJIHBL-UHFFFAOYSA-N Synonym: 2,4-dimethoxybromobenzene,1,3-dimethoxy-4-bromobenzene,4-bromo-3-methoxyanisole,benzene, 1-bromo-2,4-dimethoxy,4-bromoresorcinol dimethyl ether,4-bromoresocinol dimethyl ether,4-bromo-1,3-dimethoxybenzene,1-brom-2,4-dimethoxybenzol,pubchem3036,acmc-1c5dw PubChem CID: 87266 IUPAC-namn: 1-brom-2,4-dimetoxibensen LEDER: COC1=CC=C(Br)C(OC)=C1
| Molekylformel | C8H9BrO2 |
|---|---|
| PubChem CID | 87266 |
| MDL-nummer | MFCD00009844 |
| IUPAC-namn | 1-brom-2,4-dimetoxibensen |
| CAS | 17715-69-4 |
| InChI-nyckel | NIUZVSQOXJIHBL-UHFFFAOYSA-N |
| LEDER | COC1=CC=C(Br)C(OC)=C1 |
| Molekylvikt (g/mol) | 217.06 |
| Synonym | 2,4-dimethoxybromobenzene,1,3-dimethoxy-4-bromobenzene,4-bromo-3-methoxyanisole,benzene, 1-bromo-2,4-dimethoxy,4-bromoresorcinol dimethyl ether,4-bromoresocinol dimethyl ether,4-bromo-1,3-dimethoxybenzene,1-brom-2,4-dimethoxybenzol,pubchem3036,acmc-1c5dw |
Bedaquiline, MedChemExpress
MedChemExpress Bedaquiline (TMC207) is a diarylquinoline drug and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-drug resistant tuberculosis.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C32H31BrN2O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 555.5 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 12.5 mg/mL (22.50 mM; ultrasonic and warming and heat to 60°C) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 843663-66-1 |
| LEDER | BrC1=CC=C(N=C(OC)C([C@H]([C@@](C2=CC=CC3=C2C=CC=C3)(O)CCN(C)C)C4=CC=CC=C4)=C5)C5=C1 |
| Molekylvikt (g/mol) | 555.5 |
| Synonym | TMC207 R207910 |
| Kemiskt namn eller material | Bedaquiline |
| Procent renhet | 97.19% |
| För användning med (applikation) | COVID-19-immunoregulation |
Eprotirome, MedChemExpress
MedChemExpress Eprotirome (KB2115) is a liver-selective thyroid hormone receptor (TR) agonist. KB2115 has modestly higher affinity for TRβ than for TRα. Eprotirome reduces low-density lipoprotein (LDL) cholesterol concentrations. Eprotirome can be used for dyslipidemias and obesity research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
P7C3, MedChemExpress
MedChemExpress P7C3 is an orally bioavailable and blood-brain barrier penetrant aminopropyl carbazole, with neuroprotective effects. P7C3 can be used for the research of neurodegenerative diseases, including Parkinson's disease.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H18Br2N2O |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 474.19 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H301∣H318 |
| Löslighetsinformation | DMSO : ≥ 33 mg/mL (69.59 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 301353-96-8 |
| LEDER | OC(CNC1=CC=CC=C1)CN2C3=CC=C(Br)C=C3C4=CC(Br)=CC=C24 |
| Molekylvikt (g/mol) | 474.19 |
| Kemiskt namn eller material | P7C3 |
| Procent renhet | 98.09% |
| För användning med (applikation) | Neuroscience-Neuromodulation |
CCT020312, MedChemExpress
MedChemExpress CCT020312 is a selective EIF2AK3/PERK activator. CCT020312 elicits EIF2A phosphorylation in cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C31H30Br2N4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 650.4 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (153.75 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| CAS | 324759-76-4 |
| LEDER | O=C1NC2=C(C(C3=CC=CC=C3)=C1C4=NN(C(C4)C5=CC=C(C=C5)Br)C(CCN(CC)CC)=O)C=C(C=C2)Br |
| Molekylvikt (g/mol) | 650.4 |
| Kemiskt namn eller material | CCT020312 |
| Procent renhet | 98.11% |
| För användning med (applikation) | Cancer-Kinase/protease |
SMER28, MedChemExpress
MedChemExpress SMER28 is a positive regulator of autophagy acting via an mTOR-independent mechanism. SMER28 prevents the accumulation of amyloid beta peptide.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C11H10BrN3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 264.12 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H315∣H318∣H335 |
| Löslighetsinformation | DMSO : ≥ 32 mg/mL (121.16 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 307538-42-7 |
| LEDER | C=CCNC1=C2C=C(Br)C=CC2=NC=N1 |
| Molekylvikt (g/mol) | 264.12 |
| Kemiskt namn eller material | SMER28 |
| Procent renhet | 99.99% |
| För användning med (applikation) | Cancer-programmed cell death |
IDO-IN-12, MedChemExpress
MedChemExpress IDO-IN-12 is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO 2017181849 A1.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C13H11BrFN5O3S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 416.23 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 50 mg/mL (120.13 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1888341-29-4 |
| LEDER | FC1=CC=C(N2C(C3=NON=C3NCCSC)=NOC2=O)C=C1Br |
| Molekylvikt (g/mol) | 416.23 |
| Kemiskt namn eller material | IDO-IN-12 |
| Procent renhet | 97.64% |
| För användning med (applikation) | Cancer-programmed cell death |
ZD-4190, MedChemExpress
MedChemExpress ZD-4190 is a potent, orally available inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling, used for the treatment of cancer.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H16BrFN6O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 459.27 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 20.83 mg/mL (45.35 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 413599-62-9 |
| LEDER | COC1=CC2=C(NC3=CC=C(Br)C=C3F)N=CN=C2C=C1OCCN4N=NC=C4 |
| Molekylvikt (g/mol) | 459.27 |
| Kemiskt namn eller material | ZD-4190 |
| Procent renhet | 99.2% |
| För användning med (applikation) | Cancer-Kinase/protease |
IDO-IN-1, MedChemExpress
MedChemExpress IDO-IN-1 is a potent indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC50 of 59 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C9H7BrFN5O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 316.09 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 120 mg/mL (379.64 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Gray |
| CAS | 914638-30-5 |
| LEDER | NC1=NON=C1/C(NO)=N/C2=CC(Br)=C(F)C=C2 |
| Molekylvikt (g/mol) | 316.09 |
| Kemiskt namn eller material | IDO-IN-1 |
| Procent renhet | 95.3% |
| För användning med (applikation) | Cancer-programmed cell death |
NBD-557, MedChemExpress
MedChemExpress NBD-557 is a potentially HIV-1 inhibitor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C17H24BrN3O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 382.3 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 10 mg/mL (26.16 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 333352-59-3 |
| LEDER | O=C(C(NC1CC(C)(NC(C)(C1)C)C)=O)NC2=CC=C(C=C2)Br |
| Molekylvikt (g/mol) | 382.3 |
| Kemiskt namn eller material | NBD-557 |
| Procent renhet | 99.41% |
| För användning med (applikation) | COVID-19-anti-virus |